Fibrotic liver disease
Therapeutic area
Endocrinology
Rare disease
No
- Definition
- A liver disease characterized by the presence of excessive fibrous connective tissue in the liver.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Fibrotic liver disease
- Therapeutic area
- Endocrinology
- fibrotic liver disease
- hepatic fibrosis (disease)
- liver fibrosis (disease)
- Severity
- Severe
- Endocrinology
- Gastroenterology
- MONDO ID
- MONDO:0100430
- Parent condition
- MONDO:0005154
Related records
Broader conditions (7)
- Digestive system disorder
- Disease
- Disease by body system or component
- Endocrine system disorder
- Hepatobiliary disorder
- Human disease
- Liver disorder
Trials (246)
- 18F-FAPI PET in the Diagnosis of Liver Fibrosis
- 68Ga-FAPI PET/CT in Liver Fibrosis Patients
- A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial
- A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis
- A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection
- A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
- A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor
- A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
- A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body
- A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
- A Study of Experimental Medication BMS-986036 Given to Healthy Participants
- A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
- A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
- A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
- A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
- A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
- A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.
- A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
- Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver Fibrosis
- Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity